Pharvaris (PHVS) News Today $22.44 -0.81 (-3.48%) Closing price 04:00 PM EasternExtended Trading$22.48 +0.04 (+0.18%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PHVS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Pharvaris (NASDAQ:PHVS) Shares Gap Down - Here's What HappenedOctober 3, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Time to Buy?September 30, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Here's WhySeptember 24, 2025 | marketbeat.comPharvaris N.V. (NASDAQ:PHVS) Given Average Recommendation of "Moderate Buy" by BrokeragesSeptember 19, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Should You Buy?September 18, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Shares Up 8.3% - Here's What HappenedSeptember 11, 2025 | marketbeat.comPharvaris N.V. (PHVS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comPharvaris N.V. (PHVS) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeptember 5, 2025 | seekingalpha.comPharvaris (NASDAQ:PHVS) Stock Price Up 5.6% - Here's WhySeptember 4, 2025 | marketbeat.comPharvaris N.V. (PHVS) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 4, 2025 | seekingalpha.comPharvaris (NASDAQ:PHVS) Stock Price Up 5.9% - What's Next?August 27, 2025 | marketbeat.comPharvaris N.V. (NASDAQ:PHVS) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesAugust 27, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Upgraded to Hold at Zacks ResearchAugust 22, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Shares Up 6.2% - Here's What HappenedAugust 21, 2025 | marketbeat.comPharvaris N.V. (NASDAQ:PHVS) Short Interest UpdateAugust 20, 2025 | marketbeat.comPharvaris Advances Clinical Pipeline with Strong FinancialsAugust 20, 2025 | msn.comWhat is Leerink Partnrs' Estimate for Pharvaris Q3 Earnings?August 19, 2025 | marketbeat.comCantor Fitzgerald Increases Earnings Estimates for PharvarisAugust 17, 2025 | marketbeat.comWedbush Comments on Pharvaris' Q3 Earnings (NASDAQ:PHVS)August 17, 2025 | marketbeat.comWedbush Predicts Pharvaris' FY2029 Earnings (NASDAQ:PHVS)August 16, 2025 | marketbeat.comJMP Securities Lowers Pharvaris (NASDAQ:PHVS) Price Target to $52.00August 15, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Posts Quarterly Earnings Results, Misses Expectations By $0.07 EPSAugust 14, 2025 | marketbeat.comPharvaris price target lowered to $52 from $55 at Citizens JMPAugust 13, 2025 | msn.comPharvaris Reports Q2 2025 Financials and Advances Phase 3 StudiesAugust 12, 2025 | msn.comPharvaris Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 12, 2025 | globenewswire.comPharvaris (PHVS) Projected to Post Earnings on WednesdayAugust 6, 2025 | marketbeat.comTD Asset Management Inc Has $1.23 Million Holdings in Pharvaris N.V. (NASDAQ:PHVS)August 4, 2025 | marketbeat.comPharvaris N.V. (NASDAQ:PHVS) Given Consensus Recommendation of "Buy" by BrokeragesJuly 31, 2025 | marketbeat.comPharvaris N.V.'s (NASDAQ:PHVS) 11% loss last week hit both individual investors who own 37% as well as institutionsJuly 27, 2025 | finance.yahoo.comPharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Here's What HappenedJuly 26, 2025 | marketbeat.comPharvaris shares slide following $175 million equity offeringJuly 25, 2025 | msn.comPharvaris Raises $201 Million in Successful OfferingJuly 24, 2025 | tipranks.comPharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded WarrantsJuly 22, 2025 | globenewswire.comPharvaris Announces Proposed Public Offering of Ordinary SharesJuly 22, 2025 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Pharvaris (PHVS)July 17, 2025 | theglobeandmail.comPharvaris (NASDAQ:PHVS) Stock Price Down 5.9% - Here's What HappenedJuly 15, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - Time to Buy?July 14, 2025 | marketbeat.comBank of America Securities Reaffirms Their Sell Rating on Pharvaris (PHVS)July 12, 2025 | theglobeandmail.comPharvaris (NASDAQ:PHVS) Reaches New 1-Year High - Here's What HappenedJuly 12, 2025 | marketbeat.comPharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 ...July 11, 2025 | morningstar.comMPharvaris (NASDAQ:PHVS) Stock Price Up 9.9% - Time to Buy?July 11, 2025 | marketbeat.comPharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025July 10, 2025 | globenewswire.comPharvaris N.V. (NASDAQ:PHVS) Receives Consensus Rating of "Buy" from BrokeragesJuly 6, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Shares Gap Up - What's Next?July 3, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Trading Down 4.9% - What's Next?June 27, 2025 | marketbeat.comPharvaris Announces Clinical Trial Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2025 US HAEA National SummitJune 27, 2025 | globenewswire.comPharvaris N.V. (9EN.F) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | sg.finance.yahoo.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Bristol-Myers Squibb (BMY) and Pharvaris (PHVS)June 24, 2025 | theglobeandmail.comPharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat ...June 16, 2025 | gurufocus.comPharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat ...June 16, 2025 | gurufocus.com Get Pharvaris News Delivered to You Automatically Sign up to receive the latest news and ratings for PHVS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PHVS Media Mentions By Week PHVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHVS News Sentiment▼1.250.55▲Average Medical News Sentiment PHVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHVS Articles This Week▼13▲PHVS Articles Average Week Get the Latest News and Ratings for PHVS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Pharvaris and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Krystal Biotech News PTC Therapeutics News Jyong Biotech News Arrowhead Pharmaceuticals News Arcellx News Vaxcyte News Crinetics Pharmaceuticals News Protagonist Therapeutics News Kymera Therapeutics News MoonLake Immunotherapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHVS) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharvaris N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharvaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
